Crossref
Letter to the Editor: Early molecular switching with camizestrant in clinical practice
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.115264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Murat Kiraci.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kiraci, M. (2026). Letter to the Editor: Early molecular switching with camizestrant in clinical practice. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.115264
Vancouver
Kiraci M. Letter to the Editor: Early molecular switching with camizestrant in clinical practice. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.115264
BibTeX
@article{Kiraci2026,
author = {Kiraci, Murat},
title = {Letter to the Editor: Early molecular switching with camizestrant in clinical practice},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.115264}
}
EUVIMED